User talk:Seppi333

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Hello! You've reached my talk page. Please leave an angry trollpost, a message, or a cookie, depending on your mood – I'd prefer the latter two.
Project editor retention.svg
Editor of the week.svg
Nucleus ER.png
Seppi333
 
Editor of the Week
for the week beginning July 9, 2016
Always friendly and constructively active at and around WT:PHARM and Template talk:Infobox drug. Seppi was patient and persistent and succeeded in gaining the first pharmacology FA star in over three years.
Recognized for
Bringing Amphetamine to FA status and Adderall and Methamphetamine to GA status.
Nomination page

Contents

Wiki Journal of Medicine[edit]

I've a suggestion for you. The Wikiversity Journal of Medicine accepts submissions of medically-related images for publication. The format is to give some scientific background, describe the history of any previous versions of the image, references and sources, and the decisions made for how to present the information. It's an interesting way of having a searchable (on google scholar) cite-able record. It was featured in the signpost last week too (link).

  • E.g.: Häggström, Mikael (27 March 2014). "Diagram of the pathways of human steroidogenesis" (PDF). Wikiversity Journal of Medicine. 1 (1). doi:10.15347/wjm/2014.005.

I think your diagrams and their interactive versions would be great candidates for submission.

I think its an interesting experiment in bringing together the Wikipedia and Academic communities so I'm also submitting {{Eukaryote_gene_structure}}. T.Shafee(Evo﹠Evo)talk 01:15, 1 July 2016 (UTC)

Hmm... sounds like an interesting concept. I'll look into it. Honestly though, the vast majority of previous revisions of my images were from me checking how the SVG would render on wikipedia since I didn't know about the SVGcheck tool at the time. Face-tongue.svg Seppi333 (Insert ) 17:41, 1 July 2016 (UTC)
I think previous versions refers to other people's earlier images on the same topic (if any at all!), i.e. why was there a necessity for your better image. T.Shafee(Evo﹠Evo)talk 23:39, 1 July 2016 (UTC)
Oh, hahahaha. Ok I see now. That makes me less embarrassed about submitting some of these then. Seppi333 (Insert ) 14:28, 2 July 2016 (UTC)
Hi, I thought I'd let you know that it you're still interested in the possibility of submitting a figure review (either an existing diagram or something new), let me know. There's now another example of the sort of content that such an article can have (e.g. Gene structure). The journal's gone through a few updates so the submission process is now a lot easier. T.Shafee(Evo&Evo)talk 12:42, 25 March 2017 (UTC)
Hey there. I do plan to submit something within the next few (~3-6) months, but don't expect to do so in the more immediate future since I've got a lot of off-wiki things to deal with at the moment. I left this thread unarchived because it's on my to do list. Seppi333 (Insert ) 09:01, 26 March 2017 (UTC)

Thank you[edit]

Thank you for making and maintaining the beautiful neurochemistry diagrams. I learned about several Wikimedia features by reading Template:Catecholamine and trace amine biosynthesis's source. Seeing the attention and skill that you put into making this technical artifact so that can be flexibly used in tens of articles, including articles in other languages, really brightened my day. Thank you for all that you do here. --Chkno (talk) 07:13, 18 March 2017 (UTC)

I'm glad that you find it helpful! It takes longer to create annotated images relative to placing text in the image file itself, but I think wikitext annotations are preferable due to the utility that they provide. In any event, I appreciate your kind words. Face-smile.svg Seppi333 (Insert ) 00:00, 19 March 2017 (UTC)

Thanks[edit]

Thanks for the thanks Seppi --Iztwoz (talk) 23:18, 24 March 2017 (UTC)

NP, you deserve the credit. Face-smile.svg Seppi333 (Insert ) 23:20, 24 March 2017 (UTC)

Human brain[edit]

Thanks for having a look at the article and making some changes, Seppi333. We're aiming to nominate for GA at some point in the medium term.

It's been quite hard given the extensive role of the human brain to balance accuracy, prose length, comprehensiveness and readability. If you haven't had a look through the whole article I'd be quite grateful if you could skim along to make sure there's nothing unusual about it, given you're one of the few editors around who may have an informed view about it. There's a couple of editors (including one now blocked from editing it) so we can't speak to all the edits, and I plan on editing to finish up the modern history and clinical significance sections tonight... but for an article like this, more eyes will be better

Hope that you're well, --Tom (LT) (talk) 21:01, 25 March 2017 (UTC)

Hey LT. Sure, I'll take a look tomorrow. Seppi333 (Insert ) 09:01, 26 March 2017 (UTC)
Thanks very much Seppi333, also I and other editors on slow connections would be very grateful if you could archive some content, your talk page takes a very long time to load :)...! --Tom (LT) (talk) 09:30, 26 March 2017 (UTC)
@LT910001: Alright, I'm going to start looking at it now. Out of curiosity, how long does it take you to load my talk page on your connection? Also, how does the load time for my talk page compare to the load time for the human brain or amphetamine articles? Amphetamine is one of the few pages on Wikipedia that doesn't load immediately on my connection (i.e., it takes 1–2 seconds since it's about 208 kB ≈ 8x the current size of this page). Seppi333 (Insert ) 23:13, 26 March 2017 (UTC)
Thanks, I look forward to your comments. Honestly, when using my phone it was pretty awful. 1-2 minutes and it didn't always load. Lucky I don't have to rely on it :P. --Tom (LT) (talk) 10:07, 27 March 2017 (UTC)
@LT910001: I removed the transclusion of my talk archive since the size of that page is 360kB. My talk page should be easier to load now. Seppi333 (Insert ) 01:00, 28 March 2017 (UTC)
 :) --Tom (LT) (talk) 09:01, 28 March 2017 (UTC)

Thank you for being one of Wikipedia's top medical contributors![edit]

please help translate this message into your local language via meta
Wiki Project Med Foundation logo.svg The 2016 Cure Award
In 2016 you were one of the top ~200 medical editors across any language of Wikipedia. Thank you from Wiki Project Med Foundation for helping bring free, complete, accurate, up-to-date health information to the public. We really appreciate you and the vital work you do! Wiki Project Med Foundation is a user group whose mission is to improve our health content. Consider joining here, there are no associated costs.

Thanks again :-) -- Doc James along with the rest of the team at Wiki Project Med Foundation 18:08, 3 May 2017 (UTC)

Template editor granted[edit]

Wikipedia Template editor.svg

Your account has been granted the "templateeditor" user permission, allowing you to edit templates and modules that have been protected with template protection. It also allows you to bypass the title blacklist, giving you the ability to create and edit editnotices. Before you use this user right, please read Wikipedia:Template editor and make sure you understand its contents. In particular, you should read the section on wise template editing and the criteria for revocation.

You can use this user right to perform maintenance, answer edit requests, and make any other simple and generally uncontroversial edits to templates, modules, and edinotices. You can also use it to enact more complex or controversial edits, after those edits are first made to a test sandbox, and their technical reliability as well as their consensus among other informed editors has been established. If you are willing to process edit requests on templates and modules, keep in mind that you are taking responsibility to ensure the edits have consensus and are technically sound.

This user right gives you access to some of Wikipedia's most important templates and modules; it is critical that you edit them wisely and that you only make edits that are backed up by consensus. It is also very important that no one else be allowed to access your account, so you should consider taking a few moments to secure your password.

If you do not want this user right, you may ask any administrator to remove it for you at any time.

Useful links

Happy template editing! Alex ShihTalk 12:10, 10 July 2017 (UTC)

Thanks! I appreciate it. Seppi333 (Insert ) 14:16, 10 July 2017 (UTC)

DYK for Pavlovian-instrumental transfer[edit]

Updated DYK query.svgOn 12 July 2017, Did you know was updated with a fact from the article Pavlovian-instrumental transfer, which you recently created, substantially expanded, or brought to good article status. The fact was ... that a classically conditioned stimulus can affect operant behavior and motivation through Pavlovian-instrumental transfer? The nomination discussion and review may be seen at Template:Did you know nominations/Pavlovian-instrumental transfer. You are welcome to check how many page hits the article got while on the front page (here's how, Pavlovian-instrumental transfer), and it may be added to the statistics page if the total is over 5,000. Finally, if you know of an interesting fact from another recently created article, then please feel free to suggest it on the Did you know talk page.

Alex ShihTalk 00:02, 12 July 2017 (UTC)

Heroin addiction and/or physical dependence[edit]

Thanks for your help! :3 2601:19A:4003:50:708B:26A:171F:F407 (talk) 03:42, 14 July 2017 (UTC)

Pending changes reviewer granted[edit]

Wikipedia Reviewer.svg

Hello. Your account has been granted the "pending changes reviewer" userright, allowing you to review other users' edits on pages protected by pending changes. The list of articles awaiting review is located at Special:PendingChanges, while the list of articles that have pending changes protection turned on is located at Special:StablePages.

Being granted reviewer rights neither grants you status nor changes how you can edit articles. If you do not want this user right, you may ask any administrator to remove it for you at any time.

See also:

Malinaccier (talk) 16:26, 31 July 2017 (UTC)

Downstream effects of DA[edit]

I was wondering what you think about elaborating more about the effects of DA signalling on downstream targets such as the beta subunits of GABA, trafficking of GluA1/GluN2B, and mTOR signalling. I dont see much of that in the dopamine or dopamine receptor articles, and was wondering if you had any thoughts about where these additions would go if they were significant enough. Im considering adding a lot of it to the nucleus accumbens article, since quite a lot of this research bas focused in signalling in NAcc MSNs.Petergstrom (talk) 22:00, 30 August 2017 (UTC)

It really depends on the context of the illustration (e.g., is it specific to the nucleus accumbens and/or pathological conditions, or does it occur under physiological conditions in striatal MSNs?).
From personal experience, I can tell you it takes a lot of work to draw a detailed signal transduction diagram if the pathway is complicated. If you want to illustrate a single pathway and not a series of them (e.g., something like signaling through the D1 receptor through PKA leading to CREB phosphorylation), I'd suggest just writing it in the article text itself as opposed to drawing it; a signaling cascade like that isn't particularly difficult for a reader to follow (case in point: we have a whole article on the cAMP-dependent pathway which doesn't include any diagrams). The only reason that I felt it necessary to actually draw {{psychostimulant addiction}} is that it involved 2 signaling pathways that converge at ΔFosB CREB and DARPP32 and involve biological cross-talk at DARPP-32; describing that clearly in the article text would be very difficult and hard to follow IMO.
Anyway, I'm not sure how dopamine receptors signal to those proteins that you mentioned, but if those pathways involve a single modified signaling pathway via G protein-coupled receptor heterodimers - examples of which include the D2-TAAR1 heterodimer or CB1-OX1 heterodimer (see the 2nd paragraph) - or via receptor transactivation, it would probably be simpler to just describe the pathway in the article text. It may be harder to describe in writing if what you're referring to involves multiple signaling pathways though.
Sorry if my explanation was a bit complicated. If you can show me a diagram of the pathways you're referring to, I'd be able to advise you better. Seppi333 (Insert ) 23:07, 30 August 2017 (UTC)
This is kind of random, but I just came across this figure and thought of this thread. Face-tongue.svg Seppi333 (Insert ) 00:53, 1 September 2017 (UTC)

WP:MEDRS[edit]

We stick with secondary source generally. I am not supportive of filling articles full of case reports. IMO that is clutter. Doc James (talk · contribs · email) 17:23, 28 September 2017 (UTC)

@Doc James: It is literally two references. Two. [1][2]. That doesn't seem very cluttering to me. Seppi333 (Insert ) 17:25, 28 September 2017 (UTC)
The details are in the review article. Therefore those two are not needed. Doc James (talk · contribs · email) 17:26, 28 September 2017 (UTC)

Changing Adderall's name to Mixed Amphetamine Salts[edit]

Hey,

I think it's time that we try to follow through on the page rename from Adderall to Mixed Amphetamine Salts that was recently discussed on Talk:Amphetamine (specifically at Talk:Amphetamine/Archive 7#Mydayis). Box73 agreed when you asked him about his opinion on it and the only glimmer of opposition was from an IP editor that did not seem to be acquainted with the topic and did not further participate in the discussion after their initial comment.

I have created a draft article in my userspace with my proposed edits to Adderall in it that would sufficiently expand the scope of the article to include the other two MAS products and take the focus away from Adderall specifically and change it to the broader scope of mixed amphetamine salts. It's accessible at User:Garzfoth/Draft:Mixed Amphetamine Salts. While some additional work needs to be done to more clearly explain the differences between equivalent mixtures of amphetamine bases and actual mixtures of amphetamine salts, my recent re-read of FDA application # 208147Orig1s000 for Dyanvel made it clear to me that it is indeed completely appropriate to categorize the salts and the equivalent mixtures of bases under the same article/name, and I made enough changes to hopefully communicate the basics without being misleading (difficult to do in this case).

I am a bit uncertain about how exactly the process to proceed would work. It seems that I would need to follow the process in Wikipedia:Requested_moves#Requesting_controversial_and_potentially_controversial_moves, but I wanted to run this by you before starting anything so I could get your feedback on the proposed edits in my draft first, and I'm not certain about some of the particularities of moving this page (the problem is mainly that I don't know if it'd be better to make the edits prepared on User:Garzfoth/Draft:Mixed Amphetamine Salts when I request the move, or if I should wait until the move is approved even though the edits and the move should really go hand-in-hand — but I am also not sure if I need to reiterate all of my arguments in a move request, or if I can just briefly summarize them and link to the past two places where I went into more detail - I don't want to end up with a 35,000–45,000 char request that has to be mostly collapsed, which is approximately what it'd end up being if I actually rehashed all of my arguments within the request in full detail and included all those refs I dug up, as well as the new ones I now have...any advice on that?). Garzfoth (talk) 08:04, 14 October 2017 (UTC)

@Garzfoth: For controversial moves (e.g., moving the Adderall article), the process initially involves having a move discussion (via WP:RM) and, if a consensus is reached to move the article, the article is moved and copyedited accordingly to reflect the new page title. I don't think there's much point in working on a draft because it's entirely possible that there won't be a consensus to move the article.
Also, Adzenys XR-ODT and Dyanavel XR contain the amphetamine free base, not the 4 amphetamine salts in Adderall and Mydayis, so they're not actually "mixed salts"; those 2 drugs just contain roughly the same enantiomeric ratio (3:1 and 3.2:1, respectively) as the "mixed amphetamine salts" formulations (their enantiomeric ratio is 3:1 if measured as salts and 3.2:1 if measured as the amphetamine free base). Seppi333 (Insert ) 09:40, 14 October 2017 (UTC)
Okay, that makes sense. I adjusted the draft to refocus it solely on the literal salt products — you're right, the others may be based on Adderall and designed for functional equivalence, but they're not literally mixed amphetamine salts as the term is used, so shoehorning them into the article wouldn't be correct despite the linkage. I'll probably start a move request via WP:RM#CM soon, as I think consensus may be more realistic now that Mydayis has been fully formally launched and an even stronger and clearer precedent for the name exists than in the past. I expect some of the same tired old arguments will be trotted out again against it like they almost always are when renaming is discussed, but the copious use of the term mixed amphetamine salts in the Mydayis product monograph combined with the different marketing name and the use of the term in Adzenys/Dyanavel FDA material has nullified quite a few of the arguments used in the past. It does seem that I'll have to rehash more of my arguments when requesting the move, and keep it short unless this template allows line breaks or br tags, so that'll need to be written... Thank you for your help. Garzfoth (talk) 12:34, 14 October 2017 (UTC)

Your waffles are indeed tasty![edit]

Gaufre biscuit.jpg Thank you for the excellent work at Template talk:Tryptophan metabolism by human microbiota - you've convinced me of the value of annotated diagrams! Slashme (talk) 21:58, 2 November 2017 (UTC)
@Slashme: Glad to have helped. Face-smile.svg They're a lot more of a pain in the ass to create than regular diagrams with image text, but I think they provide much more utility to readers and editors on other wikis.
Anyway, I'm not sure if you noticed, but I cropped the right side of the image in the annotated diagram in Template talk:Tryptophan metabolism by human microbiota/af:Template:Triptofaanmetabolisme deur menslike mikrobiota yesterday to see how it looks. If you want to uncrop it in the af:Template:Triptofaanmetabolisme deur menslike mikrobiota image, just change the | wydte = 580 parameter to | wydte = 600.
The width and height parameters in {{Annotated image 4}} specify the width and height of the thumbnail for the image; the "image-width" parameter specifies the width of the image (the image's height is automatically scaled based upon that value and its aspect ratio). The reason there's two width parameters is to allow you to crop or expand the area around the top/bottom/left/right sides of any image; using the "image-top", "image-left", "image-width", "width", and "height" parameters together lets you crop/expand images like that. Seppi333 (Insert ) 22:28, 2 November 2017 (UTC)
I think that looks fine, thanks! --Slashme (talk) 09:01, 3 November 2017 (UTC)

Your signature[edit]

Please be aware that your signature uses deprecated <font> tags, which are causing Obsolete HTML tags lint errors. You are encouraged to change

[[User:Seppi333|'''<font color="#32CD32">Seppi</font>''<font color="Black">333</font>''''']] ([[User Talk:Seppi333|Insert '''2¢''']])Seppi333 (Insert )

to

[[User:Seppi333|'''<span style="color: #32CD32;">Seppi</span>''<span style="color: Black;">333</span>''''']] ([[User Talk:Seppi333|Insert '''2¢''']])Seppi333 (Insert )

That's my .—Anomalocaris (talk) 06:44, 9 November 2017 (UTC)

@Anomalocaris: That's my – LOL. Anyway, I've made the changes you've indicated. Thanks for letting me know. Face-smile.svg Seppi333 (Insert ) 06:50, 9 November 2017 (UTC)
Thanks! Anomalocaris (talk) 04:16, 19 November 2017 (UTC)

New Page Reviewing[edit]

Wikipedia New page reviewer.svg
Hello, Seppi333.

I noticed you've done some constructive editing recently.
Would you please consider becoming a New Page Reviewer? Reviewing/patrolling a page doesn't take much time but it requires a good understanding of Wikipedia policies and guidelines; currently Wikipedia needs experienced users at this task. (After gaining the flag, patrolling is not mandatory. One can do it at their convenience). But kindly read the tutorial before making your decision. Thanks. Insertcleverphrasehere (or here) 06:47, 21 November 2017‎ (UTC)

@Insertcleverphrasehere: I'm curious as to what I did that motivated you invite me to become a page patroller. Also, I figured I should let you know that the {{NPR invite}} template needs to be substituted (i.e., use {{subst:NPR invite}} instead of {{NPR invite}}); otherwise, it doesn't add your signature. Seppi333 (Insert ) 07:08, 21 November 2017 (UTC)
Thanks for the reminder about the template. I found you down at The Wikipedia:Database_reports/Editors_eligible_for_Autopatrol_privilege, then checked out your talk page. Luckily AnomieBOT has my back on the templates... :D — Insertcleverphrasehere (or here) 07:17, 21 November 2017 (UTC)

New page reviewer granted[edit]

Wikipedia New page reviewer.svg

Hello Seppi333. Your account has been added to the "New page reviewers" user group, allowing you to review new pages and mark them as patrolled, tag them for maintenance issues, or in some cases, tag them for deletion. The list of articles awaiting review is located at the New Pages Feed. New page reviewing is a vital function for policing the quality of the encylopedia, if you have not already done so, you must read the new tutorial at New Pages Review, the linked guides and essays, and fully understand the various deletion criteria. If you need more help or wish to discuss the process, please join or start a thread at page reviewer talk.

  • URGENT: Please consider helping get the huge backlog down to a manageable number of pages as soon as possible.
  • Be nice to new users - they are often not aware of doing anything wrong.
  • You will frequently be asked by users to explain why their page is being deleted - be formal and polite in your approach to them too, even if they are not.
  • Don't review a page if you are not sure what to do. Just leave it for another reviewer.
  • Remember that quality is quintessential to good patrolling. Take your time to patrol each article, there is no rush. Use the message feature and offer basic advice.

The reviewer right does not change your status or how you can edit articles. If you no longer want this user right, you may ask any administrator to remove it for you at any time. In case of abuse or persistent inaccuracy of reviewing, the right can be revoked at any time by an administrator. TonyBallioni (talk) 15:10, 21 November 2017 (UTC)

Mast cell[edit]

Hello Seppi333,

Please could you explain why my edit was wrong/bad and why you reverted it in this edit? Thank you! --Treetear (talk) 22:59, 25 November 2017 (UTC)

My bad, I've restored your edit. I must've been looking at an outdated edit history window because I was attempting to revert the edit that you reverted prior to that edit. Seppi333 (Insert ) 23:07, 25 November 2017 (UTC)
Hi, thank you for your quick response! No worries, I was genuinely curious about the reason: I was interested in learning what I could improve for next time, and you seem very knowledgeable. It happens to all of us - thanks for explaining! And finally, thank you for your many and high quality contributions! Feel free to remove our little chat here since it kinda clutters your otherwise perfect wall :) --Treetear (talk) 23:12, 25 November 2017 (UTC)

Your GA nomination of Beta-Hydroxy beta-methylbutyric acid[edit]

Hi there, I'm pleased to inform you that I've begun reviewing the article Beta-Hydroxy beta-methylbutyric acid you nominated for GA-status according to the criteria. Time2wait.svg This process may take up to 7 days. Feel free to contact me with any questions or comments you might have during this period. Message delivered by Legobot, on behalf of Tom (LT) -- Tom (LT) (talk) 06:01, 28 November 2017 (UTC)

ANI Experiences survey[edit]

The Wikimedia Foundation Community health initiative (led by the Safety and Support and Anti-Harassment Tools team) is conducting a survey for en.wikipedia contributors on their experience and satisfaction level with the Administrator’s Noticeboard/Incidents. This survey will be integral to gathering information about how this noticeboard works - which problems it deals with well, and which problems it struggles with.

The survey should take 10-20 minutes to answer, and your individual responses will not be made public. The survey is delivered through Google Forms. The privacy policy for the survey describes how and when Wikimedia collects, uses, and shares the information we receive from survey participants and can be found here:

If you would like to take this survey, please sign up on this page, and a link for the survey will be mailed to you via Special:Emailuser.

Please be aware this survey will close Friday, Dec. 8 at 23:00 UTC.

Thank you on behalf of the Support & Safety and Anti-Harassment Tools Teams, Patrick Earley (WMF) talk 21:14, 6 December 2017 (UTC)

Could you please substantiate your "Wikilinks should not be placed inside a reference quote" assertion?[edit]

Hi there! In your revert of my edit of Transactivation you commented that "Wikilinks should not be placed inside a reference quote". Could you please substantiate that? DadaNeem (talk) 22:49, 11 December 2017 (UTC)

@DadaNeem: A quotation reflects an exact replication of the text of a source. The only instance where it would be appropriate to place a link in a quote is if the link were included in the source itself. Seppi333 (Insert ) 22:53, 11 December 2017 (UTC)
I understand that where there is doubt about the intention of the quoted. Is there any doubt in this technical quote? DadaNeem (talk) 23:08, 11 December 2017 (UTC)
@DadaNeem: If you really want to add those wikilinks to the article, just summarize the quote in the article text and add the links to your summary of the quote. Seppi333 (Insert ) 23:13, 11 December 2017 (UTC)

LRT inconsistencies[edit]

Hi. You recently changed the LRT page by switching the numerator and denominator in the definition of LR. As I understand it (I am not an expert) it occurs both ways in the literature, so either way is OK, but now there are inconsistencies, I believe, with other parts of the article. e.g.: in the 'Simple hypotheses' section: 'In the form stated here, the likelihood ratio is small if the alternative model is better than the null model.', and in the 'Interpretation' section: 'The likelihood ratio test rejects the null hypothesis if the value of this statistic is too small.', and 'The numerator corresponds to the likelihood of an observed outcome under the null hypothesis. The denominator ...'. And maybe there are other inconsistencies. I don't know whether is would be better to revert to null model likelihood in numerator, or fix the statements inconsistent with your version. Perhaps you could do one or the other. Thanks. tom fisher-york (talk) 18:24, 22 December 2017 (UTC)

Looks like I was confused about who did the latest revision. I'll put this on the article's talk page as I should have. — Preceding unsigned comment added by Tomfy (talkcontribs) 18:33, 22 December 2017 (UTC)

@Tomfy: Can you link to a diff? I'm not really sure what you're talking about. Seppi333 (Insert ) 19:32, 22 December 2017 (UTC)
Nevermind, I'm assuming you're confusing me with the IP editor who made this edit. Seppi333 (Insert ) 19:39, 22 December 2017 (UTC)

Autopatrolled granted[edit]

Wikipedia Autopatrolled.svg

Hi Seppi333, I just wanted to let you know that I have added the "autopatrolled" permission to your account, as you have created numerous, valid articles. This feature will have no effect on your editing, and is simply intended to reduce the workload on new page patrollers. For more information on the autopatrolled right, see Wikipedia:Autopatrolled. Feel free to leave me a message if you have any questions. Happy editing! TonyBallioni (talk) 05:46, 23 December 2017 (UTC)

A barnstar for you![edit]

Original Barnstar Hires.png The Original Barnstar
You deserve about a thousand more barnstars than I'll ever be able to give you. Thanks for all that you do and for improving the Beta-Hydroxy beta-methylbutyric acid article. I love how this title just rolls off the tongue. I can't wait to use it a couple of times in my casual, real-life conversations. Wikipedia is lucky to have you. Best Regards, Barbara (WVS)   and Merry Christmas 13:00, 23 December 2017 (UTC)
Haha, thanks. I appreciate it. Face-smile.svg Seppi333 (Insert ) 21:45, 24 December 2017 (UTC)

Merry Xmas[edit]

Wikipedia Happy New Year.png Merry Christmas and a Prosperous 2018!

Hello Seppi333, may you be surrounded by peace, success and happiness on this seasonal occasion. Spread the WikiLove by wishing another user a Merry Christmas and a Happy New Year, whether it be someone you have had disagreements with in the past, a good friend, or just some random person. Sending you a heartfelt and warm greetings for Christmas and New Year 2018.
Happy editing,
Doc James (talk · contribs · email) 03:44, 25 December 2017 (UTC)

Spread the love by adding {{subst:Seasonal Greetings}} to other user talk pages.

Thanks James. Face-smile.svg Seppi333 (Insert ) 19:54, 25 December 2017 (UTC)

Merry Christmas[edit]

A blessed feast to you and yours. -Ad Orientem (talk) 15:22, 25 December 2017 (UTC)

Thanks. Face-smile.svg I hope you have a good Christmas/New Years! Seppi333 (Insert ) 19:54, 25 December 2017 (UTC)

Your GA nomination of Beta-Hydroxy beta-methylbutyric acid[edit]

The article Beta-Hydroxy beta-methylbutyric acid you nominated as a good article has passed Symbol support vote.svg; see Talk:Beta-Hydroxy beta-methylbutyric acid for comments about the article. Well done! If the article has not already been on the main page as an "In the news" or "Did you know" item, you can nominate it to appear in Did you know. Message delivered by Legobot, on behalf of Tom (LT) -- Tom (LT) (talk) 22:41, 25 December 2017 (UTC)

Template:Main section[edit]

Hi Seppi333, here is the hatnote from Template:Main section. Credit to Mclay1 who originally wrote this. {{Hatnote|The main section for this topic is on the page [[{{{1}}}]], in the section [[{{{1}}}#{{{2}}}|{{{2}}}]].}}

Graeme Bartlett (talk) 21:19, 17 January 2018 (UTC)
@Graeme Bartlett: Thanks! Much appreciated. Face-smile.svg Seppi333 (Insert ) 22:01, 17 January 2018 (UTC)

DYK for Beta-Hydroxy beta-methylbutyric acid[edit]

Updated DYK query.svgOn 22 January 2018, Did you know was updated with a fact from the article Beta-Hydroxy beta-methylbutyric acid, which you recently created, substantially expanded, or brought to good article status. The fact was ... that in healthy adults, HMB has been shown to increase exercise-induced gains in muscle size, muscle strength, and lean body mass, reduce muscle damage, and speed recovery from exercise? You are welcome to check how many page hits the article got while on the front page (here's how, Beta-Hydroxy beta-methylbutyric acid), and it may be added to the statistics page if the total is over 5,000. Finally, if you know of an interesting fact from another recently created article, then please feel free to suggest it on the Did you know talk page.

Gatoclass (talk) 13:31, 22 January 2018 (UTC)

Congrats on getting more than 5,000 hits and thus qualifying for addition to the Stats listing for January 2018. David notMD (talk) 14:54, 23 January 2018 (UTC)

Neat. I guess I wrote a good hook for that entry. Seppi333 (Insert ) 05:27, 24 January 2018 (UTC)
FYI - Back in the 80s and 90s I was in R&D for Clintec, an enteral nutrition company, joint venture of Baxter and Nestle. I designed close to 20 new enteral products that competed with the Ross/Abbott products, including products with high arginine, fish oil, MCTs and hydrolyzed protein. But no HMB. David notMD (talk) 08:25, 26 January 2018 (UTC)
Interesting! Since the first study that reported HMB's clinical effects in humans was published in the mid-90s, the lack of HMB-containing products isn't particularly surprising though. Face-tongue.svg Seppi333 (Insert ) 10:50, 26 January 2018 (UTC)

File:Massanutten Military Academy Shoulder Loop Insignia.jpg[edit]

Actually I am his father, and I don't know the details of where the insignia were worn. Feel free to adjust

ed

Ecragg (talk) 10:39, 9 February 2018 (UTC)

Ah, ok. Thanks for letting me know. I'll look into it when I get a chance. Seppi333 (Insert ) 04:42, 14 February 2018 (UTC)

NACC[edit]

Hey Seppi333, I just wanted to notify you as to an edit on the nucleus accumbens page I just made. From what was already written in the function section, it seemed as if the page was suggesting that increased excitability in NAcc MSNs is responsible for reward, so I changed the wording a bit, along with adding reviews of how reduced excitability is the predominant response in the NAcc.Petergstrom (talk) 17:57, 10 February 2018 (UTC)

Sorry for the late response; I've been really busy off-wiki. Sounds good; I'll take a look in a bit. Seppi333 (Insert ) 04:42, 14 February 2018 (UTC)

Wikipedia Day LA[edit]

Hello! I was very stoked to see that you RSVP'd for Wikipedia Day LA. I think that we'll have a solid turnout, but it it's anything like last year's event, there won't be a lot of Wikipedians. People tend to be interested in Wikipedia, though, which is very cool.

Give me an inch and I'll take two miles: Do you have any interest in doing a lightning talk? It can be on any subject related to the movement (I am saying that with proper sarcasm). The editing you've done is fascinating.

AND I wondered if as a statistician you could help me to address the fact (FACT) that the figures used on the List of best-selling music artists are completely inaccurate? That the formula is intrinsically flawed? I know this because I've worked in the music industry and in media forever, and there's no such thing as worldwide charts; there's no way to compute sales based on global market share when the constant varies hugely from year to year and country to country. It's all original research, poorly referenced and full of false equivalencies. I can't even interact with the two editors who essentially own the page anymore - they are completely ridiculous. (Read the Beatles/New York section here if you are up for being entertained: Talk:List of best-selling music artists/Archive 37 - I gave up after that and mentally blocked the page. It was going to make my head explode.) The outside world believes and quotes the article, and perpetuates the inaccuracies. I am convinced that you could look at the page and analyze it in, like, two seconds flat. (Please feel free to ignore me. I'm just taking advantage of my newfound knowledge of your existence.)

Nice to meet you here. Look forward to meeting you in the flesh! Julie JSFarman (talk) 08:30, 27 February 2018 (UTC)

Hi Julie. I'm going to be very busy IRL until March 10th, so I won't be able to look at and comment on the issues you discussed with that page until then. As for the lightning talks, what do those entail specifically (i.e., what length, topical restrictions, etc.)? Seppi333 (Insert ) 23:31, 28 February 2018 (UTC)
Hello again, and sorry for the delay. (I very rarely have a RL, but did this week.)
Lighting talks are five-ten minutes, and can be on anything related to Wikipedia. ("Related" is loosely defined.) I would love to hear your thoughts on systemic bias on Wikipedia; collaborating with editors who have a demonstrated expertise; statistical models of reliability (if such a thing exists). BUT, again, you can talk about whatever is of interest to you. We'll have a podium set up, but last year people sat on tables to talk - it's all pretty informal. (I'm less obsessed with the aforementioned page; I've kept myself from looking at it for a week or so, and that seems to help.) Thank you! Julie JSFarman (talk) 07:09, 4 March 2018 (UTC)
@JSFarman: Now that I actually have time for WP-related work, I'll take a look at that page you linked. As for the lightning talks, I can't think of anything in particular off the top of my head that's worth talking about. If I come up with something, I'll opt to do one of those.
From looking at the article and the archived talk page that you linked as well as the sources for the article, this appears to be a really complicated issue. My opinion doesn't really count for much since content inclusion is determined solely based upon its relative coverage in reliable sources; my opinion is technically WP:OR. However, if you're convinced that these sources aren't WP:RS-quality or are being given WP:UNDUE weight, your best bet is to take this issue to the WP:RS noticeboard or WP:NPOV noticeboard and explain why the sources are unreliable or being given undue weight; if there's consensus among the editors who weigh in on that discussion that there is an issue with RS or NPOV, that content is likely to be removed. Seppi333 (Insert ) 22:21, 19 March 2018 (UTC)
I am so sorry - I neglected to put your talk page on my watchlist and only just saw your response. Thanks for looking at the page and thanks for the very sane advice. Hope to meet you on Saturday! JSFarman (talk) 16:33, 27 March 2018 (UTC)

Cough cough[edit]

Wikimopmeme.jpg

WP:ORCP is <<<that way. -Ad Orientem (talk) 01:20, 1 March 2018 (UTC)

@Ad Orientem: LOL. I appreciate the sentiment, but I actually don't really want to wield the mop at the moment; perhaps I will sometime in the future though. Most of my interest on WP is in content creation, although I do spend a fair amount of time gnoming Wikipedia's backpages. Also, sorry about the delayed reply - I'm just catching up on my talk page messages now due to being stupidly preoccupied with RL lately. Seppi333 (Insert ) 22:03, 19 March 2018 (UTC)
How dare you allow the triviality that is the real world take precedence over an online encyclopedia! That said, I can understand not wanting the mop. But when the time is right, do step up please. The steady attrition is going to start impacting the project in the not too distant future. -Ad Orientem (talk) 01:30, 23 March 2018 (UTC)

hi[edit]

can you helpUser talk:Doc James#apparently not?(update... whenever you have time, just realized you've been out for 2 weeks)--Ozzie10aaaa (talk) 21:32, 3 March 2018 (UTC)

@Ozzie10aaaa: Looks like that thread was archived in the meantime. I talked to Doc James about doing that, but I'd still need the scripts for it to start. Seppi333 (Insert ) 22:01, 19 March 2018 (UTC)

Greetings[edit]

I left a few comments on the FA comments page for your β-Hydroxy β-methylbutyric acid article. After you leave a comment in response to my questions, I will enthusiastically endorse the article to be a FA. I'll even write the blurb for the Signpost about the promotion. Best Regards, Barbara (WVS)   12:53, 7 March 2018 (UTC)

@Barbara (WVS): I replied in your section on the FAC page. Sorry about the delay. Seppi333 (Insert ) 22:01, 19 March 2018 (UTC)
@Barbara (WVS): Thanks for your support! When you get a chance, could you place '''Support''' –  at the beginning of your last comment? That's the standard format for a support !vote at FAC. Seppi333 (Insert ) 01:35, 20 March 2018 (UTC)

A kitten for you![edit]

Cucciolo gatto Bibo.jpg

Keep up the good work! I'm very happy you finally got your second FA!

Carl Fredrik talk 23:43, 2 April 2018 (UTC)

@CFCF: Thanks. Face-smile.svg It took a lot of time and effort, but I suppose it all paid off in the end. Seppi333 (Insert ) 07:00, 10 April 2018 (UTC)

Precious three years![edit]

Precious
Cornflower blue Yogo sapphire.jpg
Three years!

--Gerda Arendt (talk) 10:27, 3 April 2018 (UTC)

Thanks Gerda. Face-smile.svg Seppi333 (Insert ) 09:15, 17 April 2018 (UTC)

Thank you for Beta-Hydroxy beta-methylbutyric acid, "a natural product in humans which is used as a medical food ingredient and dietary supplement; it has medical and athletic performance-enhancing applications for preventing/reversing muscle wasting and improving body composition respectively"! - I'd have difficulties to even remember the name, and appreciate highly what you did to make us understand. --Gerda Arendt (talk) 06:30, 28 May 2018 (UTC)

@Gerda Arendt: You're welcome! I hope you liked the article; it took a long time to comprehensively research and write an FA-quality article on a compound like that. Seppi333 (Insert ) 20:37, 30 May 2018 (UTC)

Chromium deficiency - talk[edit]

I have created new content about chromium dietary supplements. Because I have a declared COI, I placed it as New section in Chromium deficiency Talk. I am asking you and several other editors with an interest in nutrition/supplements to look at it and comment, perhaps making changes and/or stating that it is appropriate to move into the article, or not. A separate question is whether it belongs in Chromium deficiency, Chromium, or both. Thank you for the consideration. David notMD (talk) 11:49, 16 April 2018 (UTC)

Will take a look soon.  Done Seppi333 (Insert ) 09:16, 17 April 2018 (UTC)

Upcoming changes to wikitext parsing[edit]

Hello,

There will be some changes to the way wikitext is parsed during the next few weeks. It will affect all namespaces. You can see a list of pages that may display incorrectly at Special:LintErrors. Since most of the easy problems have already been solved at the English Wikipedia, I am specifically contacting tech-savvy editors such as yourself with this one-time message, in the hope that you will be able to investigate the remaining high-priority pages during the next month.

There are approximately 10,000 articles (and many more non-article pages) with high-priority errors. The most important ones are the articles with misnested tags and table problems. Some of these involve templates, such as infoboxes, or the way the template is used in the article. In some cases, the "error" is a minor, unimportant difference in the visual appearance. In other cases, the results are undesirable. You can see a before-and-after comparison of any article by adding ?action=parsermigration-edit to the end of a link, like this: https://en.wikipedia.org/wiki/Arthur_Foss?action=parsermigration-edit (which shows a difference in how {{infobox ship}} is parsed).

If you are interested in helping with this project, please see Wikipedia:Linter. There are also some basic instructions (and links to even more information) at https://lists.wikimedia.org/pipermail/wikitech-ambassadors/2018-April/001836.html You can also leave a note at WT:Linter if you have questions.

Thank you for all the good things you do for the English Wikipedia. Whatamidoing (WMF) (talk) 21:18, 19 April 2018 (UTC)

Beta-Hydroxy beta-methylbutyric acid scheduled for TFA[edit]

This is to let you know that Beta-Hydroxy beta-methylbutyric acid has been scheduled as today's featured article for 28 May 2018. Please check that the article needs no polishing or corrections. If you're interested in editing the main page text, you're welcome to do so at Wikipedia:Today's featured article/May 28, 2018. Ealdgyth - Talk 16:59, 23 April 2018 (UTC)

@Ealdgyth: Thanks for letting me know and sorry for my delayed reply; I was out of town from the 22nd to the 29th of this month. I'm glad to see that it was displayed on the main page without issue though. The article was very recently promoted to FA status, so no revisions were necessary as of when it was on the main page (2 days ago) or now. Seppi333 (Insert ) 20:44, 30 May 2018 (UTC)

Thank you for being one of Wikipedia's top medical contributors![edit]

please help translate this message into your local language via meta
Wiki Project Med Foundation logo.svg The 2017 Cure Award
In 2017 you were one of the top ~250 medical editors across any language of Wikipedia. Thank you from Wiki Project Med Foundation for helping bring free, complete, accurate, up-to-date health information to the public. We really appreciate you and the vital work you do! Wiki Project Med Foundation is a user group whose mission is to improve our health content. Consider joining here, there are no associated costs.

Thanks again :-) -- Doc James along with the rest of the team at Wiki Project Med Foundation 03:01, 26 April 2018 (UTC)

Thank You[edit]

My god, life has become soooo much easier since you mentioned sci-hub in this conversation. Being able to get any article is actually insane; I have filled up a 512 GB hard drive already. Just wanted to say thanks for that.Petergstrom (talk) 23:10, 12 May 2018 (UTC)

LOL. You're welcome. Face-smile.svg Seppi333 (Insert ) 23:13, 12 May 2018 (UTC)
And I came here to thank you for the very same thing as well, from your comment here. Has helped me tremendously! Thanks. --Treetear (talk) 11:34, 24 May 2018 (UTC)
@Treetear: No problem. It's helped me a great deal with conducting research on topics and subsequently writing/revising numerous articles since I first learned about it. Seppi333 (Insert ) 20:42, 30 May 2018 (UTC)
@CFCF: On an unrelated note: you've helped a lot of other editors. Face-tongue.svg Seppi333 (Insert ) 20:42, 30 May 2018 (UTC)

Readability of medical physiology articles.[edit]

Moved to WT:PHARM: Tom (LT) (talk) 18:18, 3 July 2018 (UTC)

Norepinephrine/levartenol[edit]

Hi Seppi, I'm not sure I agree with your revert here. I was not familiar with the term myself, but looking it up, it has seen substantial use in the literature. Also levarterenol redirects to norepinephrine, so the term really ought to appear in the article somewhere. Looie496 (talk) 13:51, 3 July 2018 (UTC)

@Looie496: they’re not actually synonymous since it refers to a specific stereoisomer: [1]. That’s an alternate name for levo-norepinephrine. Seppi333 (Insert ) 00:01, 6 July 2018 (UTC)

Edit warring at Nootropic[edit]

Hello Seppi333. You've been warned per a complaint at the edit warring noticeboard. If either of you reverts again at Nootropic without getting a prior consensus in your favor on the talk page that person may be blocked. This shouldn't discourage you from active participation on Talk. Thank you, EdJohnston (talk) 22:41, 12 July 2018 (UTC)

@EdJohnston: Thank you for following up on my post at the noticeboard. Face-smile.svg I created a new section on the talk page and requested feedback from 3 WikiProjects regarding this content at Talk:Nootropic#Coverage of CNS stimulants; hopefully a consensus for the recent or original revision will be reached sometime in the near future. On an unrelated note, I'm interested in knowing why Zefr is not required to self-revert his 4th edit revert today. I was under the impression that this was a requirement of WP:3RR, per the last paragraph. Seppi333 (Insert ) 08:04, 13 July 2018 (UTC)
Seppi333, you do get credit for opening up a proper discussion at the article talk page. However, the question you are posing is very complex. Maybe you could add a bit more motivation at the top of the proposal as to what people have been disagreeing about up til now. Also, if you want to recruit general editors, see WP:RFC for how to advertise it more widely. EdJohnston (talk) 15:47, 13 July 2018 (UTC)
I'm familiar with RFCs since I've done a few before. The only reason I didn't do one this time is that it's a technical subject matter (i.e., neuropsychopharmacology) and I think it's more valuable to get input from individuals who are familiar with the drugs in question, their biomolecular targets, and/or the cognitive processes the sources say they affect, which basically just means WT:MED/WT:PHARM/WT:NEURO. In any event, the current disagreement is literally just the differences between the versions of that section shown on the talk page. I've been fine with most of Zefr's edits in the article once he discussed them with me, but the ones he made in that section seem entirely at odds with WP:V and WP:NPOV to me. Seppi333 (Insert ) 16:21, 13 July 2018 (UTC)

Nagajoshi[edit]

My draft text did not assert that Nagajoshi synthesized amphetamine. Instead, he purifed and characterized ephedrine from Ephedra. He then devised a synthesis for *ephedrine.* (not amphetamine.) — Preceding unsigned comment added by Sbelknap (talkcontribs) 19:01, 18 July 2018 (UTC)

I'm aware. That wasn't really the issue I was referring to though; the issue was that ephedrine is used in the synthesis of methamphetamine, not amphetamine. The only reason I moved the statements about ephedrine to this article is that they aren't particularly relevant for the amphetamine article. In the context of chemical synthesis, ephedrine is much more notable in relation to methamphetamine than amphetamine. Seppi333 (Insert ) 19:18, 18 July 2018 (UTC)

Automated scripts[edit]

Beta-Hydroxy_beta-methylbutyric_acid[edit]

Why did you remove my copyedit of the HMB introduction? Everything I removed from the intro is repeated word for word in the article body, and shorter introductions are what I’m accustomed to seeing on Wikipedia. What makes the HMB article different? Dogshu (talk) 03:09, 29 August 2018 (UTC) https://en.m.wikipedia.org/w/index.php?title=Beta-Hydroxy_beta-methylbutyric_acid&oldid=856827744

I saw you also brought this up at Talk:Beta-Hydroxy beta-methylbutyric acid#Long and repetitive introduction; I've replied there. Seppi333 (Insert ) 23:17, 2 September 2018 (UTC)

7th Annual Los Angeles Wiknic[edit]

It's the 7th Annual Los Angeles Wiknic!

Sunday, September 30, 11:00-4:00 PM
Pan Pacific Park, 7600 Beverly Blvd, Los Angeles, CA 90036
Hang out. Consume crowd-sourced BBQ! Bask in the glory of late September in Los Angeles (and the glory
of our new user group, Wikimedians of Los Angeles).
RSVP (and volunteer) here.
We hope to see you there! JSFarman (talk) 02:50, 9 September 2018 (UTC)
Join our Facebook group, or follow us on Twitter!

To opt out of future mailings about LA meetups, please remove your name from this list.

NPR Newsletter No.13 18 September 2018[edit]

Hello Seppi333, thank you for your work reviewing New Pages!

The New Page Feed currently has 2700 unreviewed articles, up from just 500 at the start of July. For a while we were falling behind by an average of about 40 articles per day, but we have stabilised more recently. Please review some articles from the back of the queue if you can (Sort by: 'Oldest' at Special:NewPagesFeed), as we are very close to having articles older than one month.

Project news
As part of this project, the feed will have some larger updates to functionality next month. Specifically, ORES predictions will be built in, which will automatically flag articles for potential issues such as vandalism or spam. Copyright violation detection will also be added to the new page feed. See the projects's talk page for more info.
Other
Moving to Draft and Page Mover
  • Some unsuitable new articles can be best reviewed by moving them to the draft space, but reviewers need to do this carefully and sparingly. It is most useful for topics that look like they might have promise, but where the article as written would be unlikely to survive AfD. If the article can be easily fixed, or if the only issue is a lack of sourcing that is easily accessible, tagging or adding sources yourself is preferable. If sources do not appear to be available and the topic does not appear to be notable, tagging for deletion is preferable (PROD/AfD/CSD as appropriate). See additional guidance at WP:DRAFTIFY.
  • If the user moves the draft back to mainspace, or recreates it in mainspace, please do not re-draftify the article (although swapping it to maintain the page history may be advisable in the case of copy-paste moves). AfC is optional except for editors with a clear conflict of interest.
  • Articles that have been created in contravention of our paid-editing-requirements or written from a blatant NPOV perspective, or by authors with a clear COI might also be draftified at discretion.
  • The best tool for draftification is User:Evad37/MoveToDraft.js(info). Kindly adapt the text in the dialogue-pop-up as necessary (the default can also be changed like this). Note that if you do not have the Page Mover userright, the redirect from main will be automatically tagged as CSD R2, but in some cases it might be better to make this a redirect to a different page instead.
  • The Page Mover userright can be useful for New Page Reviewers; occasionally page swapping is needed during NPR activities, and it helps avoid excessive R2 nominations which must be processed by admins. Note that the Page Mover userright has higher requirements than the NPR userright, and is generally given to users active at Requested Moves. Only reviewers who are very experienced and are also very active reviewers are likely to be granted it solely for NPP activities.
List of other useful scripts for New Page Reviewing

  • Twinkle provides a lot of the same functionality as the page curation tools, and some reviewers prefer to use the Twinkle tools for some/all tasks. It can be activated simply in the gadgets section of 'preferences'. There are also a lot of options available at the Twinkle preferences panel after you install the gadget.
  • In terms of other gadgets for NPR, HotCat is worth turning on. It allows you to easily add, remove, and change categories on a page, with name suggestions.
  • MoreMenu also adds a bunch of very useful links for diagnosing and fixing page issues.
  • User:Equazcion/ScriptInstaller.js(info): Installing scripts doesn't have to be complicated. Go to your common.js and copy importScript( 'User:Equazcion/ScriptInstaller.js' ); into an empty line, now you can install all other scripts with the click of a button from the script page! (Note you need to be at the ".js" page for the script for the install button to appear, not the information page)
  • User:TheJosh/Scripts/NewPagePatrol.js(info): Creates a scrolling new pages list at the left side of the page. You can change the number of pages shown by adding the following to the next line on your common.js page (immediately after the line importing this script): npp_num_pages=20; (Recommended 20, but you can use any number from 1 to 50).
  • User:Primefac/revdel.js(info): Is requesting revdel complicated and time consuming? This script helps simplify the process. Just have the Copyvio source URL and go to the history page and collect your diff IDs and you can drop them into the script Popups and it will create a revdel request for you.
  • User:Lourdes/PageCuration.js(info): Creates a "Page Curation" link to Special:NewPagesFeed up near your sandbox link.
  • User:Writ Keeper/Scripts/deletionFinder.js: Creates links next to the title of each page which show up if it has been previously deleted or nominated for deletion.
  • User:Evad37/rater.js(info): A fantastic tool for adding WikiProject templates to article talk pages. If you add: rater_autostartNamespaces = 0; to the next line on your common.js, the prompt will pop up automatically if a page has no Wikiproject templates on the talk page (note: this can be a bit annoying if you review redirects or dab pages commonly).

Go here to remove your name if you wish to opt-out of future mailings. MediaWiki message delivery (talk) 23:11, 17 September 2018 (UTC)